Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00293
|
|||||
| Drug Name |
Pyroglutamic acid
|
|||||
| Synonyms |
5-oxoproline; PCA; pidolic acid
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Discovery agent [ICD11: N.A.] | Investigative | ||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C5H7NO3
|
|||||
| Canonical SMILES |
C1CC(=O)NC1C(=O)O
|
|||||
| InChI |
InChI=1S/C5H7NO3/c7-4-2-1-3(6-4)5(8)9/h3H,1-2H2,(H,6,7)(H,8,9)
|
|||||
| InChIKey |
ODHCTXKNWHHXJC-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 98-79-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 129.11 | Topological Polar Surface Area | 66.4 | ||
| Heavy Atom Count | 9 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
-0.8
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103146210
, 103205643
, 104295009
, 104668212
, 10508678
, 10539043
, 117546335
, 117609232
, 124385330
, 124812473
, 125326244
, 125341550
, 125349968
, 125377014
, 126523585
, 126595700
, 126613855
, 126678637
, 126688131
, 14747636
, 24438867
, 24857617
, 25621698
, 26699389
, 29820541
, 3139885
, 36493859
, 427849
, 50086852
, 5078796
, 51075644
, 51075645
, 57320250
, 57566652
, 57929548
, 605293
, 78579986
, 81040399
, 81040605
, 8145045
, 8150666
, 85089081
, 85089082
, 85089083
, 85246216
, 87570275
, 88834734
, 92297653
, 93621465
, 95967
|
|||||
| ChEBI ID |
CHEBI:16080
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MCT1 | Transporter Info | Monocarboxylate transporter 1 | Substrate | [1] | |
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | MCT1 | Transporter Info | Km = 4 microM | Oocytes-MCT1 | [1] | |
| References | ||||||
| 1 | Interaction of atorvastatin with the human glial transporter SLC16A1. Eur J Pharmacol. 2016 Oct 5;788:248-254. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.